Hepatitis Awareness lecture held at JSMU (sponsored by Searle Biosciences Pvt, Ltd.)
Hepatitis Screening camp at Health Expo, 2017
Local Conference participation by SBPL
SEARLE INFUSIONS AND DISPOSABLES
MEDECO IV Cannulae
MEDECO Inject Insulin
MEDECO Auto Disable (RUP) Syringe (aproved supplier of WHO and UNICEF)
MEDECO Standard Syringe
Medeset Single use I.V Infusion set (basic and Y port)
SEARLE – NS (Macsol NS) IV Infusion (1000ml, 500ml, 100ml, 50ml, 20ml)
SEARLE – DS (Macsol DS) IV Infusion (1000ml, 500ml)
SEARLE – DS 1/2 (Macsol DS) IV Infusion (500ml)
SEARLE – 5% (Macsol 5%) IV Infusion (1000ml, 500ml, 100ml)
SEARLE – RL (Macsolate D) IV infusion (1000ml, 500ml)
SEARLE – PEADS (Macsol Peads) IV Infusion (500ml)
PROTiEX Surgical Gloves – Powdered (all ranges)
PROTiEX Surgical Gloves – Powder free (all ranges)
PROTiEX Examination Gloves (all ranges)
SAFETY OF PRODUCTS
Humans vary in their biological reactions to medicinal products. This is why not all adverse reactions (side effects) associated with the use of medicinal products can be detected during clinical development, not even by the most comprehensive clinical trials.
Searle as a responsible organization focused on healthcare products safety. If you experience any unanticipated side effects, kindly report to
Please provide the following information in your email to ensure it is handled in a manner consistent with the applicable local laws:
- Name of the Searle medical product:
Description of when the patient started the medication, including dosing strength and frequency (amount and how often, e.g. 40mg twice daily). Please specify what are you using the product for. Any action taken with the medication (e.g. reduced dose, stopped) and impact of that action on the adverse event.
- The adverse event associated with the drug:
Description of details of the adverse event(s) and any additional product or procedure to treat the adverse event. Name of healthcare provider who provided treatment and contact information.
- Your name (optional) and occupation:
Please note that your personal identifying information (e.g. name, email address) will not be shared with the health authorities. Searle Pharmacovigilance unit may contact you for further information about the adverse event. If you do not wish to be contacted, you should indicate this in your email. Please specify your occupation.
- Information about the person who experienced the adverse event:
Any other medical conditions currently ongoing. Other medications currently taken (name, dosing strength, frequency, and when medication was started). Gender and age of the person taking medication (optional).